Latest News | Alembic Pharma Gets USFDA Nod for Generic Product

New Delhi, Sep 5 (PTI) Alembic Pharmaceuticals on Thursday said it has received approval from the US health regulator to market a generic drug used to treat infections caused by worms.

The company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Albendazole Tablets USP (200 mg), the drug maker said in a statement.

Also Read | Shillong Teer Results Today, September 5 2024: Know Winning Numbers, Result Chart for Shillong Morning Teer, Shillong Night Teer, Khanapara Teer, Juwai Teer and Jowai Ladrymbai Games.

The approved ANDA is therapeutically equivalent to Impax Laboratories, Inc.'s LAlbenza tablets, it added.

Albendazole tablets are indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium.

Also Read | Kolkata Fatafat Result Today: Kolkata FF Result for September 5, 2024 Declared, Check Winning Numbers and Result Chart of Satta Matka-Type Lottery Game.

It is also indicated for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.

Alembic Pharma shares on Thursday ended 2.79 per cent higher at Rs 1,145.80 apiece on the BSE.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)